**Core Concept**
Osteomalacia is a condition characterized by the softening of bones due to a deficiency of vitamin D or calcium. It is a result of impaired bone mineralization, leading to a decrease in bone density and increased risk of fractures.

**Why the Correct Answer is Right**
The correct answer is associated with the inhibition of vitamin D metabolism. Vitamin D is essential for the absorption of calcium from the gut and the mineralization of bone. The correct answer acts as a competitive inhibitor of 25-hydroxyvitamin D3 1-alpha-hydroxylase, an enzyme responsible for converting 25-hydroxyvitamin D3 to its active form, 1,25-dihydroxyvitamin D3. This leads to a decrease in the production of the active form of vitamin D, resulting in impaired calcium absorption and osteomalacia.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option may cause hypercalcemia, not osteomalacia. It is a medication used to treat hyperparathyroidism and conditions associated with hypercalcemia.
* **Option B:** This option is not typically associated with osteomalacia. It is a medication used to treat conditions such as hypothyroidism and certain types of cancer.
* **Option C:** This option may cause an increase in blood pressure, not osteomalacia. It is a medication used to treat hypertension.

**Clinical Pearl / High-Yield Fact**
Be aware that osteomalacia can be caused by a variety of factors, including inadequate dietary calcium and vitamin D, impaired vitamin D metabolism, and certain medications.

**Correct Answer: C. Aminoglutethimide**